Differences in teratogenicity of some vitamin K antagonist substances used as human therapeutic or rodenticide are due to major differences in their fate after an oral administration
Thomas Chetot, Marjorie Mouette-Bonnet, Shira Taufana, Isabelle Fourel, Sébastien Lefebvre, Etienne Benoît, Virginie Lattard
Topics & Concepts
RodenticideWarfarinVitamin K antagonistPharmacologyPharmacokineticsAntagonistVitaminFetusMedicineToxicologyInternal medicineBiologyPregnancyReceptorAtrial fibrillationGeneticsAnimal Ecology and Behavior StudiesVitamin K Research StudiesPoisoning and overdose treatments